BIOGEN INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biogen Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was -$72.9M, a 1.62% increase year-over-year.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was -$270M, a 6.14% increase year-over-year.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2023 was -$274M, a 4.14% decline from 2022.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2022 was -$264M, a 6.85% decline from 2021.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2021 was -$247M, a 20.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$274M -$10.9M -4.14% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
2022 -$264M -$16.9M -6.85% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
2021 -$247M -$42.1M -20.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 -$205M -$13.3M -6.96% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-15
2019 -$191M -$22.5M -13.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-03
2018 -$169M -$307M -222% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-03
2017 $138M +$276M Jan 1, 2017 Dec 31, 2017 10-K 2019-02-06
2016 -$138M -$321M -175% Jan 1, 2016 Dec 31, 2016 10-K 2020-02-06
2015 $183M +$18.2M +11% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-01
2014 $165M +$18.8M +12.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-02
2013 $146M +$22.2M +17.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-03
2012 $124M +$6.61M +5.63% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-04
2011 $117M -$54.1M -31.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-06
2010 $171M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.